Free shipping
ArticlesTopic 02
Odor, discharge, dryness and comfort down there. What’s normal, what isn’t, and what actually helps.
Intimate HealthEvidence check
The maintenance trial found fewer recurrences after fluconazole response. Its outcome definitions, pregnancy precautions and current supply problem matter.
Intimate HealthEvidence check
Two doses, symptom outcomes and the limits of short-term hormone measurements.
Intimate HealthComparison
Two Thai placebo-controlled studies used high-dose vitamin D2 for 12 weeks. Their results do not establish a dose to take for dryness.
Intimate HealthEvidence check
The symptom result needs its laboratory and recurrence findings beside it.
Intimate HealthEvidence check
The comparison product, symptom scale and follow-up change how these menopause studies should be read.
Intimate HealthEvidence check
An add-on trial, a replacement trial and a 2026 review answer different questions about treating confirmed vaginal yeast infections.
Intimate HealthEvidence check
The 12-week study measured symptoms and broader sexual function separately. Its gel formulation and participant counts deserve closer reading.
Intimate HealthEvidence check
A national survey, a university testing study and an STI-clinic study measured different outcomes. Their findings do not show that shaving causes an infection.
Intimate HealthEvidence check
The oral trials did not establish better symptom relief than placebo. Studies of mixed vaginal formulas answer different questions.
Intimate HealthEvidence check
Small trials tested prepared vaginal products. Their results do not establish a dose, long-term safety or equivalence to estrogen.
Intimate HealthEvidence check
Raising vitamin D levels did not reduce recurrence in a U.S. trial. A favorable Iranian study involved symptom-free BV, a different dose and a different outcome.
Intimate HealthEvidence check
Many women put off cervical screening because of the speculum exam. A self-swab for HPV is now an option in several countries. A review for France's national health authority found that validated lab tests on self-samples were as sensitive as clinician samples, though slightly less specific. In London trials, offering a kit in person got about half to two-thirds of overdue women to send one back. Here is what that means for you.
